Best Treatments for Melasma: How to Choose the Right Topical or In-Office Approach for Your Skin

Melasma is a pigmentary disorder that appears as lacy, reticulated brown patches on the skin, most frequently on the cheeks, upper lip, and forehead — and it is one of the most common yet stubbornly persistent forms of hyperpigmentation dermatologists treat. The American Academy of Dermatology (AAD) notes that melasma affects millions of people worldwide, with women — particularly those who are pregnant or taking hormonal contraceptives — disproportionately represented. The patches are completely benign, but the psychological impact on self-confidence is real, and the condition's tendency to relapse makes choosing the right treatment strategy genuinely important.

A thoughtful combination of topical actives, daily sun protection, and — when needed — in-office procedures can produce visible fading. The challenge is that no single ingredient or procedure works for everyone, and the wrong approach (especially aggressive laser treatments on darker skin tones) can worsen pigmentation rather than improve it.

Below is a side-by-side look at the most evidence-backed topical options before we go deeper on each approach.

Treatment	Mechanism	Best For	Prescription Required?	Approx. Cost
Hydroquinone (2–4%)	Inhibits tyrosinase, slows melanin production	Moderate–severe melasma; short-term use	Rx for 4% (OTC for 2%)	$15–$60
Tranexamic Acid (3–5%)	Blocks UV-induced plasminogen activation; reduces melanin transfer	Inflammatory & hormonal melasma; sensitive skin	No	$30–$115
Azelaic Acid (10–20%)	Inhibits tyrosinase; anti-inflammatory	Post-pregnancy; rosacea-prone skin	Rx for 20%	$12–$40
Kojic Acid (1–4%)	Chelates copper ions needed for tyrosinase activity	Mild–moderate melasma; combo formulas	No	$15–$50
Niacinamide (5%)	Blocks melanosome transfer to keratinocytes	Sensitive skin; maintenance	No	$10–$40
Chemical Peel (glycolic/lactic)	Accelerates epidermal turnover; removes pigmented cells	Epidermal melasma; adjunct to topicals	In-office	$100–$300/session
Laser (low-fluence Q-switched Nd:YAG)	Selectively destroys melanosomes	Recalcitrant melasma; lighter skin tones	In-office	$300–$600/session

What exactly is melasma, and why is it so hard to treat?

Melasma is a chronic, relapsing disorder of hyperpigmentation driven primarily by three factors: ultraviolet (UV) radiation, visible light, and hormonal fluctuations — particularly estrogen and progesterone. Research published in Dermatology and Therapy identifies these triggers as the reason melasma is so difficult to eradicate: even after successful fading, re-exposure to sunlight or a hormonal shift (pregnancy, starting or stopping oral contraceptives) can reactivate melanocytes and bring patches back within weeks.

The condition has three subtypes based on depth of pigmentation:

Epidermal melasma sits in the upper layers of skin and responds best to topical treatments and superficial peels.
Dermal melasma involves pigment deposited deeper in the dermis and is significantly harder to treat; topicals have limited reach.
Mixed melasma — the most common type — has both epidermal and dermal components.

A Wood's lamp examination or dermoscopy can help a dermatologist determine the subtype, which directly informs which treatments are likely to work. Dermal melasma, for instance, often requires a combination of topicals and in-office procedures, and even then results may be partial.

Dr. Sarah Sung, a board-certified dermatologist in Seattle, frames it plainly: "I tell patients to treat melasma like a chronic condition that can relapse — but with the right plan, you can stay ahead of it." That framing matters because it sets realistic expectations: the goal is management and maintenance, not a permanent cure.

Which topical ingredients actually work for melasma?

The evidence base for topical melasma treatments is broader than many people realize. Here's what the research and dermatologists consistently point to:

Hydroquinone — still the gold standard, with caveats

Hydroquinone has been the most studied depigmenting agent for decades. It works by inhibiting tyrosinase, the enzyme responsible for converting tyrosine into melanin, as the AAD explains. At 2%, it's available over the counter in the United States; at 4%, a prescription is required. Clinical studies consistently show meaningful fading over 8–12 weeks of use.

The caveats are real, however. Long-term or unsupervised use can cause ochronosis — a paradoxical darkening of the skin — particularly in individuals with darker complexions. Dermatologists typically recommend cycling patients on and off hydroquinone rather than using it indefinitely. The prescription-based Agency by Curology Dark Spot Formula takes exactly this approach: if hydroquinone is included in a patient's custom blend, the brand automatically cycles them on and off to prevent overuse.

Tranexamic acid — the rising star for sensitive skin

Tranexamic acid has rapidly become one of dermatology's favorite non-hydroquinone options for melasma. Rather than directly inhibiting tyrosinase, it blocks the interaction between keratinocytes and melanocytes that UV radiation triggers, reducing the signal that tells melanocytes to produce more pigment. Research in Dermatology and Therapy highlights its favorable tolerability profile, making it particularly suitable for sensitive skin types and those who cannot use hydroquinone.

The SkinCeuticals Discoloration Defense serum — consistently cited as the top non-prescription pick by dermatologists — combines 3% tranexamic acid with 1% kojic acid, 5% niacinamide, and 5% HEPES (a gentle exfoliating sulfonic acid). Dr. Corey L. Hartman, a board-certified dermatologist in Birmingham, Alabama, notes that "tranexamic acid and kojic acid are two active ingredients in the formula that target stubborn brown patches and inflammatory discoloration like melasma." Dr. Asmi Berry, a board-certified dermatologist in Los Angeles, uses it daily herself: "I love it as a non-hydroquinone option that works well for sensitive skin types."

Azelaic acid — the pregnancy-safe choice

Azelaic acid is a dicarboxylic acid with both tyrosinase-inhibiting and anti-inflammatory properties, making it uniquely well-suited for melasma that overlaps with rosacea or for patients who are pregnant or breastfeeding. At 10%, it's available over the counter (The Ordinary's Azelaic Acid Suspension 10% retails for around $12); at 15–20%, it requires a prescription. It tends to work more slowly than hydroquinone but carries a much lower risk of irritation or paradoxical darkening.

Kojic acid — a useful partner ingredient

Kojic acid inhibits tyrosinase by chelating the copper ions the enzyme needs to function. At concentrations of 1–4%, it produces modest fading on its own; its real value is as a combination partner with tranexamic acid, niacinamide, or retinoids. Clinical review data suggests kojic acid is particularly effective when paired with glycolic acid or other exfoliants that improve its penetration.

Niacinamide — the maintenance workhorse

Niacinamide (vitamin B3) at 5% works not by inhibiting melanin production but by blocking the transfer of melanosomes (pigment packets) from melanocytes to surrounding keratinocytes. This mechanism makes it gentler and well-tolerated by virtually all skin types. It won't produce dramatic fading on its own, but it's an excellent maintenance ingredient and a smart addition to any melasma-focused routine.

Retinoids — exfoliation and turnover support

Topical retinoids (tretinoin, retinol, adapalene) accelerate epidermal cell turnover, helping to shed pigmented cells faster and improving the penetration of other actives. The AAD notes that tretinoin is often used as part of combination formulas — most famously the Kligman formula, which combines hydroquinone, tretinoin, and a mild corticosteroid. Retinoids can cause initial irritation and photosensitivity, so they're typically introduced gradually and used at night.

How do prescription and customized formulas differ from over-the-counter options?

The fundamental difference is concentration and personalization. Over-the-counter products are formulated to be broadly safe across many skin types, which means active concentrations are kept conservative. Prescription formulas can include higher concentrations of hydroquinone (4%), tretinoin, or compounded combinations that simply aren't available on shelves.

Telehealth platforms have meaningfully expanded access to prescription-strength melasma treatment. Services like Agency by Curology match patients with licensed providers who prescribe custom blends of actives — including azelaic acid, kojic acid, hydrocortisone, and hydroquinone — based on a skin quiz and photos. At $35 for a two-month supply, this is substantially less expensive than in-office dermatology visits while still providing the oversight of a licensed prescriber.

The trade-off is that telehealth providers cannot examine your skin in person. Detailed assessments — like determining melasma subtype via Wood's lamp or ruling out conditions that mimic melasma — may require an in-person visit. If you've been using topicals for three or more months without visible improvement, an in-person consultation is worth pursuing.

Is sunscreen actually a treatment, or just prevention?

Sunscreen is both — and it is non-negotiable in any melasma management plan. UV radiation is the primary trigger for melanocyte activation, meaning that even a well-designed topical routine will underperform if sun protection is inadequate. The AAD recommends broad-spectrum SPF 30 or higher applied daily, even on cloudy days, and reapplied every two hours during outdoor activity.

Dr. Hartman is direct on this point: "While technically not a melasma treatment product, sunscreen is essential. Skin will likely be more susceptible to sun damage, which could create new melasma patches."

Two additional points worth knowing: First, visible light — not just UV — can trigger melasma, particularly in people with darker skin tones. Mineral sunscreens containing iron oxides provide broader protection against visible light than standard chemical sunscreens. Second, heat itself is a trigger. Dr. Sung notes that "even hot yoga or a long run outdoors can trigger a flare-up," which means managing heat exposure matters alongside sun avoidance.

Products like the La Roche-Posay Mela B3 UV Face Sunscreen SPF 30 combine sun protection with brightening actives (niacinamide, in this case), making them a practical two-in-one for daytime use.

When should you consider in-office procedures for melasma?

In-office procedures are generally reserved for cases where topical treatments have been used consistently for at least three months without adequate response, or where dermal melasma is confirmed and topicals are unlikely to reach the pigment effectively. Evidence reviewed in Dermatology and Therapy identifies several in-office options with meaningful clinical support:

Chemical peels

Superficial peels using glycolic acid (20–70%), lactic acid, or salicylic acid accelerate epidermal turnover and can enhance the effectiveness of topical agents. They work best for epidermal melasma and are typically performed in a series of 4–6 sessions spaced 2–4 weeks apart. Medium-depth peels (trichloroacetic acid, or TCA) can reach deeper pigment but carry a higher risk of post-inflammatory hyperpigmentation (PIH), particularly in Fitzpatrick skin types IV–VI. Any peel on darker skin tones should be performed by a dermatologist experienced with pigmented skin.

Laser and light-based treatments

Laser treatment for melasma is an area where the evidence is genuinely mixed, and caution is warranted. While Q-switched Nd:YAG lasers at low fluence have shown efficacy in some studies, research published in Dermatology and Therapy notes that aggressive laser parameters can trigger PIH — particularly in darker skin tones — and melasma frequently recurs after laser treatment without ongoing topical maintenance and sun protection.

Fractional lasers (both ablative and non-ablative) have been studied for melasma with variable results. The current consensus among dermatologists is that lasers should be considered an adjunct to topical treatment, not a replacement, and that patients should have realistic expectations about recurrence.

Intense pulsed light (IPL) carries similar caveats: it can improve epidermal melasma in lighter skin tones but risks worsening pigmentation in darker complexions.

Microneedling

Microneedling with topical brightening agents (such as tranexamic acid or vitamin C) has emerged as a promising option for melasma, particularly for patients who are not good candidates for laser. The micro-channels created by needling enhance penetration of topical actives. Early clinical data is encouraging, but larger randomized controlled trials are still needed.

How do you build a complete melasma routine?

A complete melasma routine addresses pigment production, pigment transfer, cellular turnover, and UV protection simultaneously — because melasma involves multiple pathways, and targeting only one rarely produces lasting results.

A practical framework:

Morning:

Gentle, non-stripping cleanser
Antioxidant serum (vitamin C or niacinamide) to neutralize free radical damage before UV exposure
Brightening serum (tranexamic acid, kojic acid, or azelaic acid)
Moisturizer
Broad-spectrum SPF 30+ mineral or hybrid sunscreen — reapply every two hours outdoors

Evening:

Double cleanse if you've worn sunscreen or makeup
Brightening serum or prescription topical
Retinoid (start 2–3 nights per week; increase as tolerated)
Moisturizer

Consistency over months — not weeks — is what produces results. Most dermatologists set expectations at 3–6 months for meaningful visible improvement with topicals alone. Combining topicals with in-office procedures can accelerate this timeline, but the topical routine must continue afterward to prevent relapse.

Does melasma go away on its own?

Melasma can fade spontaneously when the triggering factor is removed — most commonly after pregnancy ends or after discontinuing hormonal contraceptives. Melasma triggered by sun exposure, however, tends to persist or worsen without active treatment, because cumulative UV damage continues to stimulate melanocytes even after the initial trigger is gone.

The honest answer is: sometimes, partially, but not reliably. Patients who discontinue oral contraceptives and rigorously avoid sun exposure may see significant fading over 6–12 months. But for most people, particularly those with mixed or dermal melasma, active treatment is needed to achieve meaningful improvement, and ongoing maintenance — sunscreen, periodic use of brightening actives — is required to prevent recurrence.

Which skin tones require special consideration?

This is one of the most clinically important questions in melasma treatment, and it's often underemphasized in general skincare content. People with Fitzpatrick skin types IV–VI (medium brown to dark brown and black skin) are at higher risk for two complications:

Post-inflammatory hyperpigmentation (PIH) from aggressive treatments — certain lasers, medium-depth peels, and even some topical actives at high concentrations can cause PIH that is darker and more persistent than the original melasma.
Visible light sensitivity — darker skin tones are more reactive to visible light (400–700 nm wavelengths), meaning standard UV-only sunscreens provide incomplete protection. Iron oxide-containing mineral sunscreens are specifically recommended for this population.

Research in Dermatology and Therapy emphasizes that treatment protocols for melasma in darker skin tones should prioritize the gentlest effective approach first: azelaic acid, tranexamic acid, and niacinamide before hydroquinone, and topicals before lasers. When in-office procedures are pursued, they should be performed by providers with specific expertise in treating pigmented skin.

What are the most common mistakes people make when treating melasma?

Several patterns consistently undermine melasma treatment:

Inconsistent sunscreen use. Skipping sunscreen even occasionally — especially during peak UV hours — can undo weeks of topical progress. This is the single most common reason melasma treatments appear to "stop working."

Expecting results too quickly. Topical brightening agents work at the cellular level; meaningful fading typically takes 8–12 weeks at minimum. Switching products every few weeks prevents any single formula from having time to work.

Over-exfoliating. Aggressive physical or chemical exfoliation can trigger inflammation, which in turn stimulates melanocytes and worsens melasma. Gentle exfoliation — a low-concentration AHA 2–3 times per week, or a retinoid on alternating nights — is more effective than daily scrubbing.

Using heat-generating treatments without precautions. As Dr. Sung notes, activities that raise skin temperature — hot yoga, saunas, long outdoor runs — can trigger flares even without direct sun exposure. Wearing a wide-brimmed hat and applying SPF before any heat-generating activity helps mitigate this.

Pursuing aggressive laser treatment prematurely. Lasers are not a first-line treatment for melasma, and in the wrong hands or on the wrong skin type, they can significantly worsen the condition. Topicals and sun protection should be optimized before any laser consultation.

How do you know if a product is actually working?

Progress with melasma treatments is gradual and can be hard to perceive day-to-day. A few practical approaches:

Take consistent photographs in the same lighting every 4 weeks. Smartphone cameras in portrait mode with a fixed light source work well. Comparing images at 4, 8, and 12 weeks gives a more objective view than daily mirror checks.

Track the Melasma Area and Severity Index (MASI) — a scoring system dermatologists use that accounts for the area affected, darkness, and homogeneity of patches. While the full MASI requires clinical assessment, a simplified version can help patients track progress at home.

If there is no perceptible improvement after 12 weeks of consistent use (with daily SPF), it's worth consulting a dermatologist to reassess the subtype, check for confounding factors (ongoing hormonal triggers, heat exposure), and consider whether a prescription formula or in-office adjunct is appropriate.

Melasma management is a long game — but with the right combination of evidence-based topicals, rigorous sun protection, and realistic expectations, meaningful and lasting improvement is achievable for most people.